Literature DB >> 4321018

Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease.

B Johansson, G Klein, W Henle, G Henle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4321018     DOI: 10.1002/ijc.2910060316

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  39 in total

1.  Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies.

Authors:  G Henle; E T Lennette; M A Alspaugh; W Henle
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

Authors:  C H Ten Napel; T H The; J Van Egten-Bijker; G C de Gast; M R Halie; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

3.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

Review 4.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells.

Authors:  A Masih; D Weisenburger; M Duggan; J Armitage; R Bashir; D Mitchell; R Wickert; D T Purtilo
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

6.  Antibodies to Epstein-Barr virus in patients with cryptococcosis.

Authors:  P H Levine; R D Diamond; J I Reisher
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

7.  Immune responsiveness in Hodgkin's disease.

Authors:  P M Denton
Journal:  Br J Cancer Suppl       Date:  1973-08

8.  Antibodies to Epstein-Barr and other viruses in children with acute lymphoblastic leukaemia.

Authors:  R N Sutton; S D Marston; H J Pullen; C W Darby; R T Emond; D I Evans
Journal:  Arch Dis Child       Date:  1974-07       Impact factor: 3.791

9.  Herpesvirus group antibodies in children with Hodgkin's disease.

Authors:  J Holy; O Hrodek; J Srajer
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Establishment of peripheral lymphoid cell cultures from patients with Hodgkin's disease depending on Epstein-Barr-Virus-reactivity and cellular immunity.

Authors:  V Diehl; B Johansson
Journal:  Blut       Date:  1977-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.